Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Biotech Innovations: Overhyped?
While there’s no argument that biotechnology has dramatically improved global healthcare with the introduction of many novel biotherapeutics, there have been some huge hopes for a number of novel drug products and innovative technologies that for various reasons never came to fruition. GEN recently posted a list of 10 biotechnologies that have yet to live up to their hype, which begs the question: Is the tech or the big talk to blame?